3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
7
Small Cell Lung Carcinoma
6
Fallopian Tube Neoplasms
4
Lung Neoplasms
3
Neoplasm Metastasis
2
Ganglioneuroblastoma
2
Uterine Cervical Neoplasms
1
Sarcoma, Ewing
1
SCLC
1
Rhabdoid Tumor
1
Peritoneal Neoplasms
1
Pancreatic Neoplasms
1
Osteosarcoma
1
Neuroblastoma
1
Fallopian Tube Mucinous Adenocarcinoma
1
Extensive Stage Small Cell Lung Cancer (ES-SCLC)
1
Choroid Plexus Neoplasms
1
Central Nervous System Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Neuroendocrine
1
Interventions
Rituximab
15
Cyclophosphamide
15
Prednisone
11
Doxorubicin
10
Vincristine
7
Lenalidomide
7
ibrutinib
6
polatuzumab vedotin
4
obinutuzumab
4
glofitamab
4
fludarabine
4
Oxaliplatin
4
Magnetic Resonance Spectroscopy
4
Gemcitabine
4
venetoclax
3
fludarabine phosphate
3
Whole-Body Irradiation
3
Specimen Handling
3
R-CHOP protocol
3
Etoposide
3
Cyclosporine
3
Biopsy
3
zanubrutinib
2
prednylidene
2
pembrolizumab
2
deltacortene
2
acalabrutinib
2
Prednisolone
2
Mycophenolic Acid
2
Granulocyte Colony-Stimulating Factor
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, Large B-Cell, Diffuse
×
Topotecan
×
30 days
×
Clear all
No trials found.